Christine Graversgaard

[The Lancet Rheumatology @TheLancetRheum]

NEW—International experts express their united concerns about the European Medicines Agency's recommendation to update the summary of product characteristics and the patient information leaflet for the use of #hydroxychloroquine in #pregnancy https://t.co/QQfJMpU4vX…
@EMA_News

[Laura Andreoli @lauraandreoli80]

📣A call to #HCPs (physicians, nurses, midwifes, etc.) who prescribe or perform counselling about #antirheumaticdrugs 💊 in #pregnancy 🤰

🚨Your perspectives are needed to collect patients' unmet needs
👉please compile and RT the PRAISE Survey 📝

https://t.co/Y6lzNRsXpL

[Silvia Aguilera @sil_aps]

@christine_ga_ presents a survey on “Fertility planning, pregnancy and antirheumatics” at #EULAR2023 at the #ReHFaP meeting

[Christine Graversgaard @Graversgaard_C]

@sil_aps Thank you so much for bringing your insights and perspectives to the study group, Silvia!

[Laura Andreoli @lauraandreoli80]

Thanks to @eularYoungPARE for bringing their experiences & perspectives to the Study Group on Reproductive Health & Family Planning 🤰#EULAR2023

Great kick-off meeting for this newborn study group! 🤗

@KarenS_LDN @Christine_ga_

[The Lancet Rheumatology @TheLancetRheum]

NEW RESEARCH—Pregnancy outcomes in women with primary Sjögren's syndrome; @GregoireMDF and colleagues report data from the multicentre, prospective, GR2 study in France https://t.co/WiMIVAf7Fh

[Christine Graversgaard @Graversgaard_C]

Last day of the 2023 VTE euro spring school with these powerful women!